209 related articles for article (PubMed ID: 11052273)
1. Complement activation by anti-endothelial cell antibodies in MHC-mismatched and MHC-matched heart allograft rejection: anti-MHC-, but not anti non-MHC alloantibodies are effective in complement activation.
Diujvestijn AM; Derhaag JG; van Breda Vriesman PJ
Transpl Int; 2000; 13(5):363-71. PubMed ID: 11052273
[TBL] [Abstract][Full Text] [Related]
2. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection.
Derhaag JG; Duijvestijn AM; Damoiseaux JG; van Breda Vriesman PJ
Transplantation; 2000 May; 69(9):1899-906. PubMed ID: 10830229
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection.
Wu GD; Jin YS; Salazar R; Dai WD; Barteneva N; Barr ML; Barsky LW; Starnes VA; Cramer DV
J Heart Lung Transplant; 2002 Nov; 21(11):1174-87. PubMed ID: 12431491
[TBL] [Abstract][Full Text] [Related]
4. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
[TBL] [Abstract][Full Text] [Related]
5. Chronic renal allograft rejection: the significance of non-MHC alloantigens.
Duijvestijn A; Vlek L; Duistermaat L; van Rie H; van Breda Vriesman P
Transpl Int; 1992; 5 Suppl 1():S639-44. PubMed ID: 14621897
[TBL] [Abstract][Full Text] [Related]
6. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
7. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
[TBL] [Abstract][Full Text] [Related]
8. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides.
Vella JP; Magee C; Vos L; Womer K; Rennke H; Carpenter CB; Hancock W; Sayegh MH
Transplantation; 1999 Jun; 67(12):1523-32. PubMed ID: 10401758
[TBL] [Abstract][Full Text] [Related]
9. Involvement of antibody-dependent apoptosis in graft rejection.
Plissonnier D; Henaff M; Poncet P; Paris E; Tron F; Thuillez C; Michel JB
Transplantation; 2000 Jun; 69(12):2601-8. PubMed ID: 10910283
[TBL] [Abstract][Full Text] [Related]
10. An in vitro model for studying the role of graft endothelial cells in rat heart allograft rejection: a study of the regulation and function of heart endothelial histocompatibility antigens and cell adhesion molecules.
Derhaag JG; Duijvestijn AM; Damoiseaux JG; van Breda Vriesman PJ
Transplant Proc; 1997 May; 29(3):1717-8. PubMed ID: 9142244
[No Abstract] [Full Text] [Related]
11. Chronic renal allograft rejection. Selective involvement of the glomerular endothelium in humoral immune reactivity and intravascular coagulation.
Duijvestijn AM; van Breda Vriesman PJ
Transplantation; 1991 Aug; 52(2):195-202. PubMed ID: 1871789
[TBL] [Abstract][Full Text] [Related]
12. [The role of endothelial cells in allograft rejection].
Regele H
Pathologe; 2008 Nov; 29 Suppl 2():141-4. PubMed ID: 18820919
[TBL] [Abstract][Full Text] [Related]
13. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection.
Ferry BL; Welsh KI; Dunn MJ; Law D; Proctor J; Chapel H; Yacoub MH; Rose ML
Transpl Immunol; 1997 Mar; 5(1):17-24. PubMed ID: 9106330
[TBL] [Abstract][Full Text] [Related]
14. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
15. Endothelial activation and chronic allograft rejection.
Orosz CG
Clin Transplant; 1994 Jun; 8(3 Pt 2):299-303. PubMed ID: 7520304
[TBL] [Abstract][Full Text] [Related]
16. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
17. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
[TBL] [Abstract][Full Text] [Related]
18. Donor-specific transfusion does not mitigate but accelerates rejection of intravenously transplanted lymphocytes.
Jaskłowska-Englisz M; Podgórska D; Adamczyk G; Olszewski WL
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):365-71. PubMed ID: 8010878
[TBL] [Abstract][Full Text] [Related]
19. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
